Systematic review and meta-analysis: reporting and representation of race/ethnicity in 310 randomized controlled trials of attention-deficit/hyperactivity disorder medications
Systematic review and meta-analysis: reporting and representation of race/ethnicity in 310 randomized controlled trials of attention-deficit/hyperactivity disorder medications
Objective: to evaluate the reporting of race/ethnicity data in randomized controlled trials (RCTs) of attention-deficit/hyperactivity disorder (ADHD) medications. Secondary objectives were to estimate temporal trends in the reporting, and to compare the pooled prevalence of racial/ethnic groups in RCTs conducted in the US to national estimates.
Method: we drew on, adapted, and updated the search of a network meta-analysis by Cortese et al. (2018) up to March 2022. We calculated the percentage of RCTs reporting data on race/ethnicity of participants in the published article or in related unpublished material. Temporal trends were estimated with logistic regression. The pooled prevalence of each racial/ethnic group across US RCTs was calculated using random-effects model meta-analyses.
Results: we retained 310 RCTs (including 44,447 participants), of which 231 were conducted in children/adolescents, 78 in adults, and 1 in both. Data on race/ethnicity were reported in 59.3% of the RCTs (75% of which were conducted in children/adolescents and 25% in adults) in the published article, and in unpublished material in an additional 8.7% of the RCTs. Reporting improved over time. In the US RCTs, Asian and White individuals were under- and overrepresented, respectively, compared to national estimates in the most recent time period considered.
Conclusion: more than 30% of the RCTs of ADHD medications retained in this review did not include data on race/ethnicity in their published or unpublished reports, and more than 40% in their published articles, even though reporting improved over time. Results should inform investigators, authors, editors, regulators, and study participants in relation to efforts to tackle inequalities in ADHD research.
Diversity & Inclusion Statement: one or more of the authors of this paper self-identifies as a member of one or more historically underrepresented racial and/or ethnic groups in science. We actively worked to promote sex and gender balance in our author group. While citing references scientifically relevant for this work, we also actively worked to promote sex and gender balance in our reference list. While citing references scientifically relevant for this work, we also actively worked to promote inclusion of historically underrepresented racial and/or ethnic groups in science in our reference list.
The author list of this paper includes contributors from the location and/or community where the research was conducted who participated in the data collection, design, analysis, and/or interpretation of the work.
ADHD, race, reporting, representation, trials
Riccioni, Assia
240dd2ef-33d0-4e33-a64f-b653d1c01879
Radua, Joaquim
7443399e-6de8-48ac-a6cb-3b8663151462
Ashaye, Florence O.
c0ccd5ff-de05-4b00-9375-1a7c9a550199
Solmi, Marco
2022a2e4-774d-4811-b1db-b6dbfedbd10d
Cortese, Samuele
53d4bf2c-4e0e-4c77-9385-218350560fdb
Riccioni, Assia
240dd2ef-33d0-4e33-a64f-b653d1c01879
Radua, Joaquim
7443399e-6de8-48ac-a6cb-3b8663151462
Ashaye, Florence O.
c0ccd5ff-de05-4b00-9375-1a7c9a550199
Solmi, Marco
2022a2e4-774d-4811-b1db-b6dbfedbd10d
Cortese, Samuele
53d4bf2c-4e0e-4c77-9385-218350560fdb
Riccioni, Assia, Radua, Joaquim, Ashaye, Florence O., Solmi, Marco and Cortese, Samuele
(2023)
Systematic review and meta-analysis: reporting and representation of race/ethnicity in 310 randomized controlled trials of attention-deficit/hyperactivity disorder medications.
Journal of the American Academy of Child & Adolescent Psychiatry.
(doi:10.1016/j.jaac.2023.09.544).
Abstract
Objective: to evaluate the reporting of race/ethnicity data in randomized controlled trials (RCTs) of attention-deficit/hyperactivity disorder (ADHD) medications. Secondary objectives were to estimate temporal trends in the reporting, and to compare the pooled prevalence of racial/ethnic groups in RCTs conducted in the US to national estimates.
Method: we drew on, adapted, and updated the search of a network meta-analysis by Cortese et al. (2018) up to March 2022. We calculated the percentage of RCTs reporting data on race/ethnicity of participants in the published article or in related unpublished material. Temporal trends were estimated with logistic regression. The pooled prevalence of each racial/ethnic group across US RCTs was calculated using random-effects model meta-analyses.
Results: we retained 310 RCTs (including 44,447 participants), of which 231 were conducted in children/adolescents, 78 in adults, and 1 in both. Data on race/ethnicity were reported in 59.3% of the RCTs (75% of which were conducted in children/adolescents and 25% in adults) in the published article, and in unpublished material in an additional 8.7% of the RCTs. Reporting improved over time. In the US RCTs, Asian and White individuals were under- and overrepresented, respectively, compared to national estimates in the most recent time period considered.
Conclusion: more than 30% of the RCTs of ADHD medications retained in this review did not include data on race/ethnicity in their published or unpublished reports, and more than 40% in their published articles, even though reporting improved over time. Results should inform investigators, authors, editors, regulators, and study participants in relation to efforts to tackle inequalities in ADHD research.
Diversity & Inclusion Statement: one or more of the authors of this paper self-identifies as a member of one or more historically underrepresented racial and/or ethnic groups in science. We actively worked to promote sex and gender balance in our author group. While citing references scientifically relevant for this work, we also actively worked to promote sex and gender balance in our reference list. While citing references scientifically relevant for this work, we also actively worked to promote inclusion of historically underrepresented racial and/or ethnic groups in science in our reference list.
The author list of this paper includes contributors from the location and/or community where the research was conducted who participated in the data collection, design, analysis, and/or interpretation of the work.
Text
Riccioni_JAACAP_2023
- Accepted Manuscript
More information
Accepted/In Press date: 18 October 2023
e-pub ahead of print date: 25 October 2023
Additional Information:
Funding Information:
The authors have reported no funding for this work. Disclosure: Prof. Cortese has served on the advisory board of the Association for Child and Adolescent Mental Health (ACAMH). He has received honoraria from ACAMH and the British Association for Psychopharmacology. He has served as deputy editor of Evidence Based Mental Health (now BMJ Mental Health), associate editor of Child and Adolescent Mental Health, and on the editorial board of the Journal of Child Psychology and Psychiatry. Drs. Riccioni, Radua, and Solmi and Ms. Ashaye have reported no biomedical financial interests or potential conflicts of interest.
Publisher Copyright:
© 2023
Keywords:
ADHD, race, reporting, representation, trials
Identifiers
Local EPrints ID: 486070
URI: http://eprints.soton.ac.uk/id/eprint/486070
ISSN: 1527-5418
PURE UUID: 99fce1ef-541b-4cff-b1d4-2d1e0864b3cb
Catalogue record
Date deposited: 08 Jan 2024 17:43
Last modified: 25 Oct 2024 04:01
Export record
Altmetrics
Contributors
Author:
Assia Riccioni
Author:
Joaquim Radua
Author:
Florence O. Ashaye
Author:
Marco Solmi
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics